Clinical trial
Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity
NCT01593397 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity
- Lead sponsor
- Stanford University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 30, 2011
- Completion date
- September 30, 2017
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.